Payne Fletcher 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jan 16, 2018
Insider Transaction Report
Form 4
Payne Fletcher
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-12+26,000→ 26,000 totalExercise: $15.13Exp: 2028-01-12→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]The Option vests monthly over a period of four years commencing January 12, 2018.